Autres langues Predictive Oncology Inc.

Actions

POAI

US74039M3097

Temps réel estimé Cboe BZX Autres places de cotation 20:18:23 17/05/2024			Varia. 5j.	Varia. 1 janv.
1,68 ^USD	0,00 %		+2,63 %	-49,15 %

15/05	Transcript : Predictive Oncology Inc., Q1 2024 Earnings Call, May 15, 2024
01/05	Wall Street devrait ouvrir en baisse avant la décision de la Fed sur les taux d'intérêt ; les chiffres de l'emploi privé dépassent les prévisions	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q1 Revenue $419,646	15/05
Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update	15/05
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	13/05
Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024	10/05
Predictive Oncology : Material Agreement - Form 8-K	06/05
Wall Street Set to Open Lower Ahead of Fed Rate Decision; Private Employment Figures Top Forecasts	01/05
Investors Await Fed Rate Decision as US Futures Trend Lower in Wednesday's Premarket	01/05
Top Premarket Gainers	01/05
Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine	30/04
Predictive Oncology Inc. Announces Significant Progress with FluGen in Development of Intranasal Flu Vaccine	30/04
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting	25/04
FUJIFILM Wako Chemicals U.S.A. Corporation and Predictive Oncology Announce Collaboration to Reduce Protein Interference in Bacterial Endotoxin Detection Testing of Biopharmaceuticals	25/04
Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	24/04
Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update	28/03
Predictive Oncology Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
Predictive Oncology to Participate in Upcoming Investor Conferences	21/02
Predictive Oncology Inc. Announces Resignation of Pamela Bush, as Chief Business Officer, Effective from February 15, 2024	08/02
Predictive Oncology to Participate in Upcoming San Francisco Conferences	02/01
Earnings Flash (POAI) PREDICTIVE ONCOLOGY Posts Q3 Revenue $715,056	14/11
Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update	14/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Predictive Oncology Inc.

Actions

POAI

US74039M3097

Autres langues

Filtres